全球週边支架与植入市场

到 2030 年，全球週边支架植入市场将达到 56 亿美元

全球週边支架和植入市场规模预计在2024年为40亿美元，预计到2030年将达到56亿美元，2024年至2030年的复合年增长率为6.0%。裸金属支架是本报告分析的细分市场之一，预计其复合年增长率为6.8%，到分析期结束时规模将达到33亿美元。覆膜支架细分市场在分析期间的复合年增长率预计为5.2%。

美国市场规模估计为 11 亿美元，中国市场预期复合年增长率为 9.6%

美国外周支架植入市场规模预计2024年达到11亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到12亿美元，在2024-2030年的分析期间内，复合年增长率为9.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.9%和5.9%。在欧洲，预计德国市场的复合年增长率为3.9%。

全球週边支架和植入市场—主要趋势和驱动因素摘要

为什么週边支架植入对于恢復动脉疾病的血流至关重要？

週边支架植入是一种用于疏通肢体狭窄或阻塞动脉的医疗设备，尤其适用于周边动脉疾病(PAD)。这些支架提供结构支撑，保持血管畅通，恢復血液循环，并预防组织缺血和截肢等併发症。支架经由导管植入，是一种微创的外科搭桥手术治疗方法。

由于週边动脉疾病 (PAD) 与糖尿病、吸烟和老龄化密切相关，置入术已成为治疗方法，因为传统的血管成形术可能无法保证这些部位的长期通畅。支架设计和置入技术的不断改进正在提高支架的耐用性和患者预后。

科技如何发展以提高功效和安全性？

支架创新的重点在于提高径向强度、柔韧性和长期通畅性，同时最大限度地减少血管再阻塞和骨折。镍钛合金基自动扩张型支架因其对运动和血管压缩的适应性，广泛应用于週边血管。药物释放型支架 (DES) 和药物涂层支架 (DCS) 可释放紫杉醇等抗增殖药物，以降低血管再阻塞风险。

生物可吸收支架仍在评估中，但有望提供临时锚固，同时减少长期併发症。改进的支架输送系统、更细的导管以及影像辅助置入工具正在提高手术的精确度。此外，专为复杂解剖结构（例如膝下动脉 (BTK)）设计的新型支架正在支持治疗适应症的扩展。

市场成长集中在哪里以及哪些条件推动了采用？

血管外科中心、导管室和先进医疗体系的介入放射科的发展最为迅速。北美和欧洲凭藉其完善的周边动脉疾病 (PAD)筛检和介入基础设施，在手术量方面处于领先地位。由于人口老化、糖尿病盛行率上升以及血管治疗可及性的提高，亚太地区的支架植入术数量正在激增。

支架置入的主要驱动因素包括间歇性跛行、危急性肢体缺血和慢性完全阻塞。随着支架置入程序变得更加简化且资源密集度降低，该装置在门诊和门诊手术中心的应用正在不断扩大。支架也被纳入早期週边动脉疾病 (PAD) 的管理策略中，以改善功能预后并防止进展为危急性肢体缺血。

週边支架和植入市场的成长受到多种因素的推动…

週边支架和植入市场的成长受到许多因素的推动，例如周边动脉疾病盛行率的上升、支架材料和设计的进步，以及人们对微创血管介入治疗的日益偏好。药物释放型和自动扩张型支架在临床上的日益普及，正在改善患者的长期疗效，并支持该手术的更广泛应用。

支架的可视性、灵活性以及与血管动力学相容性的提升提高了手术的安全性。门诊血管内治疗投入的增加、支持性报销政策的推行以及介入医师队伍的不断发展，进一步推动了市场扩张。随着人口老化和血管危险因子的增多，週边置入术仍然是全球週边动脉疾病 (PAD) 治疗策略的基石。

部分

产品（裸金属支架、涂层支架、药物释放型支架）、最终用户（医院最终用户、门诊手术中心/门诊最终用户）、动脉（颈动脉支架、Fem-Pop 动脉支架、髂动脉支架、Infrapop 动脉支架）

受访公司范例

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical（WL Gore）
• iVascular
• JOTEC GmbH（CryoLife）
• Medinol
• Medtronic
• MicroPort Scientific
• SMT（Sahajanand Medical Tech）
• Terumo Corporation
• Translumina Therapeutics

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Peripheral Stent Implants Market to Reach US$5.6 Billion by 2030

The global market for Peripheral Stent Implants estimated at US$4.0 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Bare Metal Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Covered Stents segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Peripheral Stent Implants market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Peripheral Stent Implants Market - Key Trends & Drivers Summarized

Why Are Peripheral Stent Implants Critical in Restoring Blood Flow in Arterial Disease?

Peripheral stent implants are medical devices used to open narrowed or blocked arteries in the limbs, particularly in cases of peripheral artery disease (PAD). These stents provide structural support to keep vessels open, restore blood circulation, and prevent complications such as tissue ischemia or amputation. They are deployed via catheter-based procedures, offering a minimally invasive alternative to surgical bypass.

PAD is strongly associated with diabetes, smoking, and aging, making stenting a central intervention in vascular medicine. Stents are particularly important in treating femoropopliteal and iliac artery blockages, where traditional angioplasty may not offer long-term patency. Continued refinement in stent design and deployment techniques is improving durability and patient outcomes.

How Are Technologies Advancing for Improved Efficacy and Safety?

Stent innovation is focused on increasing radial strength, flexibility, and long-term patency while minimizing restenosis and fracture. Nitinol-based self-expanding stents are widely used for peripheral vessels due to their adaptability to movement and vessel compression. Drug-eluting stents (DES) and drug-coated stents (DCS) release antiproliferative agents like paclitaxel to reduce the risk of re-narrowing.

Bioabsorbable stents, though still under evaluation, offer the potential for temporary scaffolding with reduced long-term complications. Improved stent delivery systems, low-profile catheters, and imaging-assisted placement tools are enhancing procedural precision. Additionally, new stents designed specifically for challenging anatomies such as below-the-knee (BTK) arteries are supporting expanded treatment indications.

Where Is Market Growth Concentrated and Which Conditions Are Driving Adoption?

Adoption is highest in vascular surgery centers, catheterization labs, and interventional radiology units across developed healthcare systems. North America and Europe lead in procedural volume due to well-established PAD screening and interventional infrastructure. Asia-Pacific is witnessing rapid growth in stent procedures driven by aging populations, increased prevalence of diabetes, and improving access to vascular care.

The primary drivers of stent implantation include intermittent claudication, critical limb ischemia, and chronic total occlusions. Device adoption is expanding in outpatient and ambulatory surgical centers as stenting procedures become more streamlined and less resource-intensive. Early-stage PAD management strategies are also incorporating stents to improve functional outcomes and prevent progression to severe limb ischemia.

Growth in the Peripheral Stent Implants market is driven by several factors…

Growth in the peripheral stent implants market is driven by factors such as rising incidence of peripheral artery disease, advancements in stent material and design, and growing preference for minimally invasive vascular interventions. Expanding clinical use of drug-eluting and self-expanding stents is improving long-term outcomes and supporting broader procedural adoption.

Improvements in stent visibility, flexibility, and compatibility with vessel dynamics are enhancing procedural safety. Increasing investments in outpatient endovascular procedures, supportive reimbursement policies, and training of interventional specialists are further fueling market expansion. As population aging and vascular risk factors continue to rise, peripheral stenting remains a cornerstone of PAD treatment strategies worldwide.

SCOPE OF STUDY:

The report analyzes the Peripheral Stent Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bare Metal Stents, Covered Stents, Drug Eluting Stents); End-Use (Hospitals End-Use, Ambulatory Surgery Centers / Outpatient End-Use); Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical (W. L. Gore)
• iVascular
• JOTEC GmbH (CryoLife)
• Medinol
• Medtronic
• MicroPort Scientific
• SMT (Sahajanand Medical Tech)
• Terumo Corporation
• Translumina Therapeutics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Peripheral Stent Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Peripheral Arterial Disease (PAD) Spurs Demand for Endovascular Stent Implants
  • Growth in Minimally Invasive Interventions Throws the Spotlight on Self-Expanding and Balloon-Expandable Stent Technologies
  • OEM Innovation in Drug-Eluting and Bioabsorbable Peripheral Stents Enhances Long-Term Patency and Reduces Restenosis
  • Expansion of PAD Screening Programs and Aging Population Strengthens Procedural Volumes in Lower Limb Revascularization
  • Improved Imaging and Navigation Systems Support Accurate Stent Deployment in Complex Anatomies
  • OEM Collaboration With Vascular Surgeons Drives Innovation in Tapered and Flexible Stent Platforms
  • Surge in Demand for Below-the-Knee (BTK) and Superficial Femoral Artery (SFA) Stents Expands Device Portfolios
  • Regulatory Approvals and Favorable Clinical Outcomes Fuel Adoption of Next-Generation Peripheral Stents
  • Increased Preference for Ambulatory Vascular Procedures Supports Use of Low-Profile, Deliverable Stent Systems
  • OEM Focus on Radiopaque Markers and Scaffold Design Enhances Intraoperative Precision and Post-Procedure Monitoring
  • Integration of Stent Systems With Drug-Coated Balloons Supports Hybrid Therapy Models for High-Risk Lesions
  • Growing Use of Nitinol and Cobalt-Chromium Materials Enhances Durability and Fracture Resistance
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Peripheral Stent Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Fem-Pop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Iliac Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Infrapop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• JAPAN
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• CHINA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• EUROPE
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• FRANCE
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• GERMANY
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• INDIA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
• AFRICA
  • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030

IV. COMPETITION